Hydrogenetics, Inc. (HYGN)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 20, 2025
Hydrogenetics Statistics
Total Valuation
Hydrogenetics has a market cap or net worth of 36,326.
Market Cap | 36,326 |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Hydrogenetics has 363.26 million shares outstanding.
Current Share Class | 363.26M |
Shares Outstanding | 363.26M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +18.57% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.11 |
P/TBV Ratio | 0.11 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.21, with a Debt / Equity ratio of 1.49.
Current Ratio | 6.21 |
Quick Ratio | 6.21 |
Debt / Equity | 1.49 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -6.08 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -31.71% |
Return on Invested Capital (ROIC) | -35.01% |
Return on Capital Employed (ROCE) | -41.63% |
Revenue Per Employee | n/a |
Profits Per Employee | -650,086 |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.00% in the last 52 weeks. The beta is -3,325.26, so Hydrogenetics's price volatility has been lower than the market average.
Beta (5Y) | -3,325.26 |
52-Week Price Change | -99.00% |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.00 |
Relative Strength Index (RSI) | 47.66 |
Average Volume (20 Days) | 117,385 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 38.66 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -304,957 |
Pretax Income | -650,086 |
Net Income | -650,086 |
EBITDA | -304,343 |
EBIT | -304,957 |
Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 815,482 in cash and 488,617 in debt, giving a net cash position of 326,865 or 0.00 per share.
Cash & Cash Equivalents | 815,482 |
Total Debt | 488,617 |
Net Cash | 326,865 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | 327,293 |
Book Value Per Share | 0.00 |
Working Capital | 684,191 |
Cash Flow
Operating Cash Flow | -293,990 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Hydrogenetics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -442.20% |
Shareholder Yield | n/a |
Earnings Yield | -1,789.59% |
FCF Yield | n/a |
Stock Splits
The last stock split was on October 3, 2008. It was a reverse split with a ratio of 0.0001.
Last Split Date | Oct 3, 2008 |
Split Type | Reverse |
Split Ratio | 0.0001 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |